🇺🇸 FDA
Patent

US 9128080

Modified T cell receptors and related materials and methods

granted A61KA61K38/00A61P

Quick answer

US patent 9128080 (Modified T cell receptors and related materials and methods) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Sep 03 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Sep 08 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 03 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K38/00, A61P, A61P31/00, A61P35/00